Alzheimer's Disease Clinical Trials in Irvine, California

4 studies are recruiting for alzheimer's disease in Irvine, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease

    Alzheimer's disease (AD) is a progressive, irreversible neurological disorder and is the most common cause of dementia in the elderly population. Clinical symptoms of the disease may begin with occasional forgetfulness such as misplacement of items, forgetting important dates or events, and may pro…

    Stage
    Phase 1
    Ages
    50 to 90
    Site
    Irvine Center for Clinical Research /ID# 277752, Irvine, California
    Locations
    13 in total
    Run by
    AbbVie

    See if you can join NCT07599670 on ClinicalTrials.gov

  2. A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

    The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease

    Stage
    Phase 3
    Ages
    60 to 85
    Site
    Irvine Clinical Research, Irvine, California
    Locations
    127 in total
    Run by
    Bristol-Myers Squibb

    See if you can join NCT06976203 on ClinicalTrials.gov

  3. A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease

    This study will evaluate the efficacy and safety of trontinemab in participants with biomarker evidence of Alzheimer's Disease (AD) pathology but with no cognitive or functional impairment, who are at risk for progression to mild cognitive impairment (MCI) due to AD or dementia due to AD.

    Stage
    Phase 3
    Ages
    55 to 80
    Site
    Irvine Center for Clinical Research, Irvine, California
    Locations
    7 in total
    Run by
    Hoffmann-La Roche

    See if you can join NCT07717411 on ClinicalTrials.gov

  4. A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

    This is a multicentre, randomized, double-blind, placebo-controlled, parallel group Phase II study to evaluate the efficacy and safety of VHB937 in participants with early AD followed by an Extension. The double-blind part is 72 weeks long, followed by an extension.

    Stage
    Phase 2
    Ages
    50 to 85
    Site
    Irvine Center for Clinical Research, Irvine, California
    Locations
    74 in total
    Run by
    Novartis Pharmaceuticals

    See if you can join NCT07094516 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.